The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge ...

Hemodialysis (HD)-related factors also alter drug clearance. Vigabatrin: in patients with renal impairment the dose should be decreased based on creatinine clearance. The effect of dialysis on ...

Novo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk ...

This approach is claimed to improve organ recovery and potentially eliminate future renal replacement therapy (RRT) requirements, including dialysis. The SCD has also gained FDA breakthrough device ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

initiation of renal replacement therapy, a 50% and greater decline in estimated glomerular filtration rate, acute kidney failure, and chronic kidney injury. The combination therapy of [SGLT2 ...

Replacement therapy: may be substituted for the titrated components. Severe renal impairment: titrate slower. ≥75yrs, or hepatic impairment: not for initial use (initially use amlodipine alone ...

Treating seizures in patients with renal failure, including those on dialysis ... so an understanding of how each drug is affected by kidney disease and dialysis is critical in order to make ...